Evidence map›Paper›PMID 40111580›Full record

ArticleAIDS and behavior2025

Challenges Faced by Perinatally-Infected Kenyan Adolescents and Youth Living with HIV During the COVID-19 Pandemic.

Manjot Singh, Winstone Nyandiko, Allison Delong, Celestine Ashimosi, Dennis Munyoro, Janet Lidweye, Jack Nyagaya, Whitney Biegon, Josephine Aluoch, Ashley Chory and 7 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Manjot SinghWarren Alpert Medical School, Brown University, Providence, RI, USA.ORCID http://orcid.org/0000-0003-4524-6226
Winstone NyandikoMoi University College of Health Sciences, Eldoret, Kenya.
Allison DelongCenter for Statistical Sciences, Brown University, Providence, RI, USA.
Celestine AshimosiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Dennis MunyoroAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Janet LidweyeAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Jack NyagayaAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Whitney BiegonAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Josephine AluochAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Ashley ChoryIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Edwin SangAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Eslyne JepkemboiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Millicent OridoAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
Vladimir NovitskyWarren Alpert Medical School, Brown University, Providence, RI, USA.
Joseph W HoganCenter for Statistical Sciences, Brown University, Providence, RI, USA.
Rachel VreemanIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Rami KantorWarren Alpert Medical School, Brown University, Providence, RI, USA. rkantor@brown.edu.ORCID http://orcid.org/0000-0003-3659-1108

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Addressing HIV drug resistance research gaps in a cohort of perinatally infected Kenyan children and adolescentsR01AI147333 · NIAID · MIRIAM HOSPITAL · PI KANTOR, RAMI, VREEMAN, RACHEL CHRISTINE · 2019 to 2024
$3.9M
Brown Moi Partnership for Biostatistics Training in HIV-NAMBARID43TW010050 · FIC · BROWN UNIVERSITY · PI JOSEPH W HOGAN · 2015 to 2026
$3.2M
Emerging Infectious Disease Scholars at Brown UniversityR25AI140490 · NIAID · BROWN UNIVERSITY · PI Silvia Shinpei Chiang · 2018 to 2026
$3.0M
HIV Drug Resistance, Monitoring and TransmissionK24AI134359 · NIAID · MIRIAM HOSPITAL · PI Rami Kantor · 2018 to 2026
$1.3M
FIC NIH HHS D43 TW010050FIC NIH HHS D43TW010050NIAID NIH HHS K24 AI134359NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI147333NIAID NIH HHS R25 AI140490NIH HHS K24 AI134359NIH HHS P30 AI042853NIH HHS R01 AI147333
6 · The paper itself

Abstract

Wellness challenges experienced by adolescents and youth living with HIV (AYLWH) during COVID-19 are unknown and could guide HIV care in resource-limited settings. Between February/2021 and July/2022, perinatally-infected AYLWH at the Academic Model Providing Access to Healthcare (AMPATH) in western Kenya completed surveys assessing psychological, physical, socioeconomic, and antiretroviral nonadherence challenges and underwent viral load (VL) testing evaluating for virologic (VL > 40 copies/mL) or treatment (VL > 1,000 copies/mL) failure. Patterns in challenges, nonadherence, and VL measures by enrolment were evaluated using general additive models. Associations between challenges and nonadherence scores were quantified using linear regression; associations between non-adherence and failure were quantified using logistic regression. Both were adjusted for age, gender, and clinic. Among 442 participants enrolled in this cross-sectional study (median age 17 years, 49% female), 89% reported challenges (48% psychological, 66% physical, 62% socioeconomic) and 74% reported nonadherence. Significant between-individual variations by enrolment date were noted in physical challenges (e.g., illnesses and hospitalizations). Reporting more psychological, physical, or socioeconomic challenges were each associated with higher nonadherence. Higher nonadherence was associated with virologic and treatment failure (OR = 1.22 per 1-unit higher nonadherence, 95% CI = 1.01-1.47, p < 0.036; and OR = 1.29, 95% CI = 1.01-1.64, p < 0.035, respectively). Kenyan AYLWH faced psychological, physical, and socioeconomic challenges during the COVID-19 pandemic. Although longitudinal studies are needed to determine whether these challenges exceed pre-pandemic levels or contribute to the observed increased antiretroviral nonadherence and treatment failure, our findings provide support for the important relationships among these measures and may help clinicians and caregivers identify opportunities for interventions to support this vulnerable population.

Indexed as

COVID-19HIV InfectionsMedication AdherenceAdolescentAnti-HIV AgentsCross-Sectional StudiesFemaleHumansInfectious Disease Transmission, VerticalKenyaMaleSARS-CoV-2Socioeconomic FactorsViral LoadYoung AdultAnti-HIV AgentsAdolescentsAntiretroviral adherenceCOVID-19HIVLow-resource setting

Identifiers

PMID40111580
PMCPMC12308764

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.